Immediate Impact
1 by Nobel laureates 5 from Science/Nature 70 standout
Citing Papers
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
2022 Standout
Works of Michele Texter being referenced
Rationale and Design of the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Study11See Appendix Afor the list of participants in the MIRACL study. That Evaluates Atorvastatin in Unstable Angina Pectoris and in Non–Q-Wave Acute Myocardial Infarction
1998
Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator Group.
1994
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michele Texter | 249 | 50 | 105 | 112 | 11 | 470 | |
| Paolo Rizzini | 323 | 15 | 41 | 85 | 12 | 473 | |
| Jianqing She | 107 | 19 | 174 | 71 | 28 | 509 | |
| Tattersall Rb | 86 | 43 | 24 | 92 | 7 | 429 | |
| Philippe Tellier | 93 | 47 | 191 | 113 | 12 | 528 | |
| J. Flack | 87 | 8 | 63 | 107 | 12 | 476 | |
| Asma Noureen | 141 | 12 | 37 | 345 | 16 | 534 | |
| Damir Perisa | 102 | 6 | 68 | 197 | 11 | 530 | |
| Yenh-Chen Hsein | 83 | 12 | 25 | 62 | 12 | 425 | |
| Robert J. Zwiener | 60 | 7 | 64 | 199 | 14 | 532 | |
| Kurt Quitzau | 301 | 15 | 22 | 55 | 10 | 445 |
All Works
Loading papers...